|
|
| | GSK-2018682 Basic information |
| Product Name: | GSK-2018682 | | Synonyms: | GSK-2018682;CPD1224;4-[5-[5-Chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-1H-indole-1-butanoic acid;S1PR-1 agonist GS2018682;1H-Indole-1-butanoic acid, 4-[5-[5-chloro-6-(1-methylethoxy)-3-pyridinyl]-1,2,4-oxadiazol-3-yl]-;LPL Receptor,Inhibitor,inhibit,Lysophospholipid Receptor,GSK-2018682,GSK 2018682,GSK2018682 | | CAS: | 1034688-30-6 | | MF: | C22H21ClN4O4 | | MW: | 440.88 | | EINECS: | | | Product Categories: | | | Mol File: | 1034688-30-6.mol |  |
| | GSK-2018682 Chemical Properties |
| Boiling point | 666.9±65.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF:30.0(Max Conc. mg/mL);68.05(Max Conc. mM)
DMSO:66.36(Max Conc. mg/mL);150.52(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:3):0.25(Max Conc. mg/mL);0.57(Max Conc. mM) | | form | A crystalline solid | | pka | 4.73±0.10(Predicted) |
| | GSK-2018682 Usage And Synthesis |
| Uses | GSK 2018682 is a sphingosine 1-phosphate receptor modulator, a disease-modifying therapy for multiple sclerosis. An agonist. | | storage | Store at -20°C |
| | GSK-2018682 Preparation Products And Raw materials |
|